As GQC, a division of PQE Group, we are excited to announce yet another strategic partnership that aligns with our mission to deliver safe, effective, and fully compliant medical cannabis solutions from cultivation to market, with a leading analysis and research laboratory, Ambra Life, which specializes in analytical and consulting services across the food, pharmaceutical, and cosmetic sectors, including medical cannabis. At the heart of this partnership lies a shared commitment to quality, compliance, and innovation as we mark a key milestone in the evolution of quality and compliance within the medical cannabis industry by combining PQE Group’s 25+ years of life sciences quality know-how with Ambra’s specialized analytical laboratory expertise to offer 360-degree support to businesses throughout the medical cannabis value chain.
Teaming up with Ambra Life will give clients access to end-to-end support across the entire medical cannabis lifecycle as we integrate our engineering expertise from designing and building processing facilities to managing HVAC systems, energy optimization, technology transfer, and ensuring GACP and GMP compliance. Ambra Life’s cutting-edge specialized lab and analytical services, which include cannabinoid analysis for potency determination, comprehensive contaminant screening for heavy metals and pesticides, microbiological testing, and environmental monitoring, complement our quality and compliance services and fit perfectly with our goal to provide integrated, future-ready solutions that help our clients navigate complex regulatory landscapes and bring high-quality medical cannabis products to market with confidence.
A Multifunctional Collaboration for Turnkey Projects
The life sciences regulatory landscape, under which medical cannabis falls, is always evolving, and our partnership with Ambra Life solidifies our commitment to assist the medical cannabis sector in navigating regulatory compliance and developing compliant, high-quality cannabis products. As a part of PQE Group, our deep understanding of global and local regulations, combined with Ambra’s ISO 9001 and ISO 17025 certifications, means our valued clients around the world can be assured that their products will meet the most stringent quality requirements across global markets.
Our partnership, formalized through a Memorandum of Understanding (MoU), will go a long way in advancing the cannabis industry as we support our clients with everything they need to succeed, from GACP and GMP certifications to training, technology transfer, hygienic production environments, and a smooth go-to-market strategy from a global perspective.
Our Shared Commitment to Patients and the Medical Cannabis Industry
Our commitment to our clients’ success means our priority is, and always has been, the safety and well-being of the millions of patients around the world who rely on medical cannabis therapies. With this collaboration, our goal is to ensure that medical cannabis products reach patients faster while complying with regulatory procedures and strengthening quality and transparency across the value chain. Ambra Life’s strong track record in lab analysis, paired with our hands-on experience in regulatory and engineering support, means our clients and patients around the world can count on safe, well-made therapies that meet the highest standards.
Our partnership with Ambra Life is more than just a business alliance; it is a shared commitment to advancing the medical cannabis industry by raising quality standards and combining our complementary strengths to support turnkey projects that improve both product development and patient outcomes. Together, we are moving one step closer to making the medical cannabis industry more reliable and patient-centered by shaping the future of safe, effective, and accessible therapies.
